Skip to main content
MedX Health Corp. logo

MedX Health Corp. — Investor Relations & Filings

Ticker · MDX ISIN · CA5850901037 TSXV Manufacturing
Open in API
Filings indexed 135 across all filing types
Latest filing 2026-04-21 Regulatory Filings
Country CA Canada
Listing TSXV MDX

About MedX Health Corp.

https://www.medxhealth.com/

MedX Health Corp. develops and distributes advanced medical devices and telehealth solutions, specializing in non-invasive skin assessment and Teledermatology. The company's core offering centers on its proprietary SIAscopy® technology and the DermSecure® platform. SIAscopy enables highly accurate, non-invasive skin assessments by mapping chromophores (collagen, blood, and melanin) through multiple sub-dermal image views, supporting the early detection of skin cancer. The FDA-approved and CE-accredited DermSecure platform provides rapid data analysis and functional Electronic Health Records (EHR) to clinicians and dermatologists across 38 territories worldwide. The platform is built for interoperability using HL7 FHIR protocols. MedX is recognized as a global leader in Teledermatology, offering a system with a proven catch rate for suspicious moles within 72 hours. Furthermore, the company manufactures and markets phototherapy medical devices (MedX Laser Therapy) utilized for pain relief and wound healing applications.

Recent filings

Filing Released Lang Actions
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a Canadian securities regulatory form (Form 45-106F1) for reporting an exempt distribution under National Instrument 45-106. It is neither a financial report, earnings release, nor board/management change document, but rather a compliance/regulatory filing detailing distribution terms, purchaser information, compensation, etc. It does not fit any more specific category and therefore falls under the general Regulatory Filings category (RNS).
2026-04-21 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings Classification · 1% confidence The document is a Canadian securities regulatory form (Form 45-106F1 Report of Exempt Distribution) filed on SEDAR+, detailing an exempt distribution of securities under NI 45-106. It is neither an earnings release nor an annual/interim report, nor does it announce a meeting or management change. It is a statutory regulatory filing without a more specific category in our taxonomy. Therefore, it falls under the fallback category for miscellaneous regulatory filings.
2026-04-21 English
News release - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a press release announcing an application for a final extension of a non-brokered private placement of convertible loan notes, detailing terms of the financing, extension dates, interest rates, conversion rights, and agent commissions. This clearly falls under updates on company fundraising and financing activities rather than an annual or interim report, AGM materials, or dividend notice. Therefore, it is classified as a Capital/Financing Update.
2026-04-15 English
News release - English.pdf
Regulatory Filings
2026-04-15 English
News release - English.pdf
Management Reports Classification · 1% confidence The document is a 'Year in Review' operational update from MedX Health Corp. It provides a narrative summary of the company's strategic progress, operational milestones, product developments, and management changes throughout the 2025 fiscal year. It is not a formal audited financial report (10-K/IR) nor a simple announcement of a report (RPA). It functions as a management-led review of business performance and outlook, which aligns best with the Management Reports (MDA) category, as it details business trends, operational investments, and strategic outlook rather than just announcing quarterly earnings or specific regulatory filings.
2025-12-15 English
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a press release announcing the appointment of Dr. Symon D. Cotton as Strategic Advisor to the Company, which constitutes a change in senior management/advisory team. This matches the ‘Board/Management Information’ category.
2025-09-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.